US clinical trials
Anticipated to begin in 2021
The goal: to test the ability of Elenagen to enhance standards of care for
- Triple negative breast cancer
- Ovarian cancer
For any inquiries, please contact: info@curelab.com
For any inquiries, please contact: info@curelab.com